Steinberg M, Borzelleca J F, Enters E K, Kinoshita F K, Loper A, Mitchell D B, Tamulinas C B, Weiner M L
Hercules Incorporated, Wilmington, Delaware 19894, USA.
Regul Toxicol Pharmacol. 1996 Oct;24(2 Pt 1):149-54. doi: 10.1006/rtph.1996.0120.
This article presents a set of proposed guidelines for the safety assessment of new pharmaceutical excipients. These guidelines were developed by the Safety Committee of the International Pharmaceutical Excipients Council and represent a new, scientifically based approach to establishing conditions for the safe use of proposed pharmaceutical excipients utilizing various routes of human exposure. They are based upon the best currently available toxicological science and have taken the deliberations of the International Conference on Harmonization into consideration. These guidelines were developed because there are no regulatory agency guidelines currently available which specifically address the toxicological testing of a material intended for use as an excipient in pharmaceutical preparations. Only materials which have been previously permitted for use in a pharmaceutical preparation or which have been permitted for use in foods may be considered safe under current practices. If implemented, these guidelines should expedite the review of a proposed new excipient by regulatory agencies.
本文提出了一套关于新型药用辅料安全性评估的拟议指南。这些指南由国际药用辅料理事会安全委员会制定,代表了一种新的、基于科学的方法,用于确定通过各种人体接触途径安全使用拟用药用辅料的条件。它们基于当前可得的最佳毒理学科学,并考虑了国际协调会议的审议情况。之所以制定这些指南,是因为目前没有监管机构的指南专门针对拟用作药物制剂辅料的材料的毒理学测试。根据当前做法,只有先前已被允许用于药物制剂或已被允许用于食品的材料才可能被视为安全。如果实施,这些指南应能加快监管机构对拟用新型辅料的审查。